Biogen Idec Shifting Tysabri Sales Force To Avonex Detail

Biogen Idec will shift the focus of its Tysabri sales force to Avonex promotion following the marketing suspension of the newer multiple sclerosis agent, the company said

More from Archive

More from Pink Sheet